Planet Labs PBC
For the period ended Jul 31, 2025. Filed Sep 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2025 · Filed Sep 8, 2025
PL$14.27-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Six Months Ended July 31, | ||
|---|---|---|
| (in thousands) | 2025 | 2024 |
| Operating activities | ||
| Net loss | $(35,220) | $(67,961) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities | ||
| Depreciation and amortization | 21,704 | 26,248 |
| Stock-based compensation, net of capitalized cost of $1,318 and $1,292, respectively | 25,998 | 24,638 |
| Change in fair value of warrant liabilities | (4,708) | (928) |
| Change in fair value of contingent consideration | 676 | 1,924 |
| Other | 1,538 | (1,275) |
| Changes in operating assets and liabilities | ||
| Accounts receivable | 2,363 | 32 |
| Prepaid expenses and other assets | 272 | 1,278 |
| Accounts payable, accrued and other liabilities | (4,342) | 4,084 |
| Deferred revenue | 75,813 | (1,149) |
| Deferred hosting costs | 1,026 | 954 |
| Net cash provided by (used in) operating activities | 85,120 | (12,155) |
| Investing activities | ||
| Purchases of property and equipment | (28,410) | (25,061) |
| Capitalized internal-use software | (2,420) | (2,916) |
| Maturities of available-for-sale securities | 27,131 | 46,808 |
| Sales of available-for-sale securities | 9,254 | 150,211 |
| Purchases of available-for-sale securities | (22,361) | (81,656) |
| Business acquisition, net of cash acquired | — | (1,068) |
| Purchases of licensed imagery intangible assets | (892) | (4,292) |
| Other | — | (300) |
| Net cash provided by (used in) investing activities | (17,698) | 81,726 |
| Financing activities | ||
| Proceeds from the exercise of common stock options | 8,451 | 300 |
| Payments for withholding taxes related to the net share settlement of equity awards | (12,436) | (4,485) |
| Proceeds from employee stock purchase program | 1,163 | 702 |
| Payments of contingent consideration for business acquisitions | (4,820) | (1,283) |
| Other | (2,521) | (340) |
| Net cash used in financing activities | (10,163) | (5,106) |
| Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents | 5,677 | (34) |
| Net increase in cash and cash equivalents, and restricted cash and cash equivalents | 62,936 | 64,431 |
| Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period | 129,994 | 102,198 |
| Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period | $192,930 | $166,629 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.